Madrigal Pharmaceuticals
Price & Volume
Stats
See more52W Range | $265-$615 |
Market Cap | $11.7B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $958.4M |
Revenue Growth (YoY) | 210.8% |
Gross Profit (12 Mos) | $902.2M |
Diluted EPS | -$12.87 |
News
See moreYahoo Finance • 5 days ago
Madrigal Pharmaceuticals (MDGL) Surged on Strong Sales of Its Rezdiffra Drug
Yahoo Finance • 10 days ago
This New $193 Million Bet Targets a Biotech With $689 Million in Revenue and a Potential Turnaround Story
Yahoo Finance • 10 days ago
This $116 Million Buy Joins a 360% Stock Run and Seemingly Signals Conviction in a Key Drug Launch
Yahoo Finance • 22 days ago
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
About
CEO | Mr. William J. Sibold |
CFO | Ms. Mardi C. Dier |
Address | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 915 |
